NFYA-Mediated TTK Up-Regulation Drives Fast Cell Cycle Progression and Its Inhibition Leads to Mitotic Catastrophe in Triple Negative Breast Cancer
Cancers · 22.04.2026 · 18 (9) · 1324
DOI: 10.3390/cancers18091324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 22.04.2026. Verfasst von Nianqiu Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Breast…. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key R&D Program of China, the Natural Science Foundation of China, the Science and Technology Program of Guangzhou.
Abstract (Originalsprache)
Background/Objectives: Triple-negative breast cancer (TNBC) is frequently characterized by notably elevated Ki-67 expression, a hallmark of uncontrolled rapid cell-cycle progression. However, the underlying mechanisms remain unclear, leading to limited therapeutic options.
Methods
In this study, hub gene was identified through integrated bioinformatic analysis of public datasets (TCGA-BRCA and METABRIC). Subsequent functional validation was performed both in vitro and in vivo using siRNA-mediated knockdown and small-molecule inhibitors. Phenotypic effects—including cell viability, cell cycle distribution, DNA synthesis, and clonogenic survival—were comprehensively assessed using MTT assays, flow cytometry, EdU, and colony formation assays. Protein-level changes were confirmed by Western blotting and immunohistochemistry (IHC). To dissect the transcriptional regulation of the key hub gene TTK, we first predicted potential upstream transcription factors using the JASPAR database; binding specificity was then validated through in silico motif analysis, luciferase reporter assays, and chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR).
Results
The mitotic kinase TTK is significantly overexpressed in TNBC compared with non-TNBC breast cancers. Notably, TTK overexpression exhibited a strong positive correlation with elevated Ki-67 indices and reduced overall survival in TNBC patients. Functional validation demonstrated that pharmacological or genetic inhibition of TTK effectively induced G2/M cell-cycle arrest and potently suppressed TNBC proliferation in both in vitro cell cultures and in vivo xenograft models. Mechanistically, TTK overexpression stems from enhanced transcriptional initiation driven by the transcription factor NFYA binding to the CCAAT box in the TTK promoter—an interaction newly identified here. Concurrently, TTK blockade disrupted spindle assembly checkpoint (SAC) signaling via BUB1B/MAD1L1 downregulation, triggering mitotic arrest and catastrophe.
Conclusions
Collectively, these findings establish TTK as a key cell-cycle regulator driving TNBC proliferation. More importantly, targeting mitotic control through TTK inhibition represents an efficient strategy to impede the aberrantly fast cell cycle progression in TNBC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University,…
- Breast Surgery Ward 2, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming 650100, China.
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
- Breast Cancer Center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China.
- The Department of Ultrasound, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
ORCID-Profile: Nianqiu Liu, Weihan Cao, Xiaoting Jiang, Jinna Lin, Qiang Liu
Förderung
- the National Key R&D Program of China
- the Natural Science Foundation of China
- the Science and Technology Program of Guangzhou
- the Beijing Medical Award Foundation
- the Yunnan Province Major Science and Technology Special Project
- the Research Project of Beijing Science and Technology Innovation Medical Development Foundation
- the Yunnan Fundamental Research Kunming Medical University Projects
- the Young Talent Fund of Yunnan Provincial Education Department
Zitieren
APA
Liu, N., Zhu, M., Cai, Z., Wang, J., Cao, W., Shi, Q., Wang, L., Jiang, X., Zhou, J., Lin, J., Yang, W., Gan, H., Nie, J., & Liu, Q. (2026). NFYA-Mediated TTK Up-Regulation Drives Fast Cell Cycle Progression and Its Inhibition Leads to Mitotic Catastrophe in Triple Negative Breast Cancer. Cancers, 18(9), 1324. https://doi.org/10.3390/cancers18091324
Vancouver
Liu N, Zhu M, Cai Z, Wang J, Cao W, Shi Q, et al. NFYA-Mediated TTK Up-Regulation Drives Fast Cell Cycle Progression and Its Inhibition Leads to Mitotic Catastrophe in Triple Negative Breast Cancer. Cancers. 2026;18(9):1324. doi:10.3390/cancers18091324
BibTeX
@article{Liu2026,
author = {Liu, Nianqiu and Zhu, Mengdi and Cai, Zijie and Wang, Jingru and Cao, Weihan and Shi, Qianfeng and Wang, Linghan and Jiang, Xiaoting and Zhou, Jing and Lin, Jinna and Yang, Wang and Gan, Huipei and Nie, Jianyun and Liu, Qiang},
title = {NFYA-Mediated TTK Up-Regulation Drives Fast Cell Cycle Progression and Its Inhibition Leads to Mitotic Catastrophe in Triple Negative Breast Cancer},
journal = {Cancers},
year = {2026},
volume = {18},
number = {9},
pages = {1324},
doi = {10.3390/cancers18091324}
}
EUVIMED